Article metrics

Download PDFPDF

TP021/#1540  Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to February 2024

AbstractFullPdf
Nov 20236507
Dec 20235108
Jan 20243304
Feb 20243200
Total181019